Sector Chart Adaptimmune Therapeutics plc

Equities

ADAP

US00653A1079

Market Closed - Nasdaq 21:00:00 20/05/2024 BST 5-day change 1st Jan Change
1.1 USD -0.90% Intraday chart for Adaptimmune Therapeutics plc -5.98% +38.71%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
281M - - -
115B
107B
21.6B -
22.31B -
19.19B